Compliance SweepBack to stories →
← Back to stories
Governance & business operationsConditional reminder

Eugia recalls one lot of vancomycin injection to the hospital level for glass particulate

Eugia US LLC announced on November 6, 2026 a voluntary nationwide recall, to the hospital/healthcare facility/user level, of one lot (3VM26026A) of Vancomycin Hydrochloride for Injection USP (United States Pharmacopeia) 1.25g/Vial-30mL because a glass particle was found inside a vial; FDA posted the announcement on November 9, 2026. The lot shipped to wholesalers nationwide from September 2 through September 15, 2026, and holders are told to discontinue use and quarantine it immediately.

Gloved hands hold a clear glass vial containing colorless liquid inside a stainless steel hood.
Illustrative artwork; not evidence of the actual people, products or events described.

Current status

On November 15, 2026, FDA's posting of the Eugia announcement still showed content current as of November 9, 2026, and FDA's drug enforcement records (openFDA) returned no Eugia record with a report date from October 1 through November 15, 2026, so this check did not establish an FDA recall classification. FDA's MedWatch feed listed no later item on the recall.

Who this affects

Hospitals, health-system pharmacies and infusion sites holding Eugia vancomycin hydrochloride for injection 1.25 g vials, lot 3VM26026A.

Why it matters

The company says there is a reasonable probability that use of product containing glass particulates can cause serious adverse health consequences such as blockage and clotting in blood vessels, with greater susceptibility in neonates, infants and patients with compromised organ function. Inference: any unit of lot 3VM26026A still in a pharmacy, satellite or automated cabinet remains a patient-safety exposure until it is quarantined and returned.

Required actions

  • None stated as a legal requirement; the company announcement directs holders of the lot to discontinue use and quarantine immediately (2026-11-06 announcement).

Scope and timing

Authority status
Other (company-initiated voluntary recall announcement posted by FDA)
Responsible owner
Pharmacy
Publication date
2026-11-09 (FDA publish date)
Other dates
2026-11-06 company announcement date; lot shipped 2026-09-02 to 2026-09-15

Not established

FDA recall classification not established.

Earlier article: November 8, 2026 edition →

Sources

Complete edition and supplemental material

This article in the complete report →

Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.

Read the entire Compliance Sweep report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies